Aayush Wellness Ltd (AAYUSH) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Aayush Wellness Ltd on NSE and BSE, with an AI summary of each filing.
Press Release on declaration of Un-audited Financial Results for the quarter and half year ended September 30, 2026.
Press Release · 03 Nov 2026, 11:26 pm
Aayush Wellness Reports Steady H1 FY27 Growth with Expanding Nutraceutical Portfolio Aayush Wellness reported H1 FY27 consolidated total income of ₹7,061.82 lakhs, up 10.61% YoY from ₹6,384.84 lakhs, with consolidated PAT rising 5.86% YoY to ₹250.10 lakhs. For Q2 FY27, consolidated total income grew 9.17% QoQ to ₹3,685.67 lakhs, delivering PAT of ₹108.48 lakhs. Standalone H1 FY27 total income reached ₹5,111.22 lakhs with PBT up 7.56% YoY to ₹254.96 lakhs. Growth was supported by targeted preventive health launches, including Calcium Vitamin Tablets on 16th Oct'26, alongside previous additions in respiratory and metabolic wellness segments.
Submission of Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026.
Outcome · 03 Nov 2026, 11:18 pm
Aayush Wellness Reports H1 FY27 Consolidated Results With PAT Up 5.86% YoY Aayush Wellness approved unaudited H1 FY27 results on 3rd Nov'26, posting consolidated total income of ₹7,061.82 lakhs, up 10.61% YoY from ₹6,384.84 lakhs in H1 FY26. Consolidated PAT grew 5.86% YoY to ₹250.10 lakhs compared to ₹236.26 lakhs. For Q2 FY27, consolidated total income rose 9.17% QoQ to ₹3,685.67 lakhs with PAT at ₹108.48 lakhs. Standalone H1 FY27 revenue from operations reached ₹4,980.71 lakhs, and PBT stood at ₹254.96 lakhs. The board also appointed M/s NKM & Associates as Secretarial Auditor for FY 2026–27.
Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026.
Financial Result · 03 Nov 2026, 11:13 pm
Aayush Wellness Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 3,620 (-9.3% YoY | +9.3% QoQ) ■ EBITDA: 44.2 (-21.5% YoY | -42.9% QoQ) ■ EBITDA Margin (%): 1.2 (-19 bps YoY | -112 bps QoQ) ■ PAT: 108 (-10.1% YoY | -23.4% QoQ) ■ EPS (INR): 0.22 (-12.0% YoY | -24.1% QoQ)
Aayush Wellness Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated ....
Intimation · 03 Nov 2026, 5:30 am
Aayush Wellness Boards to Consider Q2 and H1 Earnings on 3rd Nov'26 Aayush Wellness Limited has scheduled a Board of Directors meeting on 3rd Nov'26 to consider and approve the unaudited standalone and consolidated financial results, along with the Limited Review Report, for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in the company's securities, which closed on 1st Oct'26, will reopen 48 hours after the declaration of the financial results.
Aayush Wellness Expands into USD 16.29 Billion Bone & Joint Health Segment with New Calcium & Vitamin Supplement.
Press Release · 16 Oct 2026, 7:13 pm
Aayush Wellness Expands Nutraceutical Portfolio with Bone and Joint Health Launch Aayush Wellness Limited announced on 16th Oct'26 the expansion of its nutraceutical portfolio with the launch of Aayush Calcium Vitamin Tablets, targeting the USD 16.29B bone and joint health market within the USD 178B global dietary supplements space. Formulated with Calcium Citrate, Vitamin D2, Magnesium, Zinc, and Folic Acid, the product targets widespread domestic nutritional gaps, where 80% to 90% of the population faces Vitamin D deficiency and over 50% of adults miss daily calcium requirements.
Submission of Voting Results and Scrutinizer''s Report of the 42nd Annual General Meeting.
Annual General Meeting · 01 Oct 2026, 4:56 pm
Proceedings of the 42nd Annual General Meeting of the Company held on Tuesday, September 29, 2026, through VC/OAVM.
Annual General Meeting · 29 Sept 2026, 11:35 pm
Cut-off Date i.e. Tuesday, September 22, 2026, for E-voting for AGM.
Others · 12 Sept 2026, 10:55 pm
Resignation of Mr. Naveenakumar Kanjaru from the position of Managing Director of the Company.
Change in Management · 09 Sept 2026, 11:45 pm
Aayush Wellness Managing Director Naveenakumar Kunjaru Resigns Effective September 2026 Aayush Wellness Limited announced the resignation of Mr. Naveenakumar Kunjaru (DIN: 07087891) from his position as Managing Director, effective 9th Sep'26. The departure is attributed to personal and family commitments, with confirmation that no other material reasons exist for the resignation. Mr. Kunjaru will continue to serve as a Non-Executive Independent Director across multiple board committees at Empower India Limited.
Submission of 42nd Annual Report for FY 2025-26 of Aayush Wellness Limited
Others (Uncategorized) · 08 Sept 2026, 2:50 am
Notice of the 42nd Annual General Meeting for FY 2025-26 through VC/ OAVM.
Annual General Meeting · 08 Sept 2026, 2:22 am
Outcome of the Board Meeting held on September 03, 2026, inter alia approving the Notice of the 42nd Annual General Meeting of the Company and declaration of Annual General Meeting for ....
Others (Uncategorized) · 03 Sept 2026, 9:46 pm
Reply and Clarification on Price Movement sought by BSE Limited.
Others (Uncategorized) · 02 Sept 2026, 12:07 am
Aayush Wellness Clarifies Stock Price Movement to BSE In a response dated Sep 01, '26, to an inquiry from BSE Limited regarding recent significant stock price movement, Aayush Wellness (AAYUSH) has clarified it is not in possession of any undisclosed information or impending announcements that could be influencing the share price. The company stated it has complied with all disclosure requirements under SEBI regulations and will continue to promptly inform exchanges of any material events. The exchange's query was dated Aug 31, '26.
The Exchange has sought clarification from Aayush Wellness Ltd on August 31, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Others (Uncategorized) · 01 Sept 2026, 1:04 am
Aayush Wellness Enters India''s Rs. 18,913 Cr Respiratory Healthcare Market with Lung Care Tablets for Smoking-Exposed and Respiratory-Concerned Consumers.
Press Release · 29 Aug 2026, 5:37 pm
Aayush Wellness Enters India's ₹18,913 Cr Respiratory Market Aayush Wellness Limited has launched "Lung Care Tablets" on 29 Aug'26, marking its entry into India's respiratory healthcare market. This market, valued at ₹18,913 Cr, recorded sales of ₹18,912.64 Cr in 2025, up 10% YoY from ₹17,199.40 Cr in 2024. The product targets consumers exposed to smoking and pollution, expanding the company's preventive wellness portfolio. This strategic move aims to address a significant health need, as India accounts for 30.28% of global deaths from respiratory diseases, and create long-term investor value.
Press Release on Unaudited Financial Results of the Company for the quarter ended June 30, 2026
Press Release · 13 Aug 2026, 11:34 pm
Aayush Wellness Reports Strong Q1 FY27 with 46% YoY Revenue Growth Aayush Wellness reported strong Q1 FY27 results with consolidated revenue rising 46.3% YoY to ₹33.11 crore. Profit After Tax (PAT) grew 22.6% YoY and a significant 150.8% QoQ to ₹1.42 crore, driven by scale and efficiency gains. This resulted in an EPS of ₹0.29, up 20.8% YoY from ₹0.24. Key growth drivers included product portfolio expansion and improved distribution efficiency. Management highlighted strong demand, improved operating leverage, and a focus on Tier 2/3 markets and international expansion to sustain growth.
Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
Outcome · 13 Aug 2026, 11:25 pm
Aayush Wellness Q1 FY27: Strong Revenue Growth, Profit Rises Sharply Aayush Wellness reported strong Q1 FY27 results, with consolidated revenue rising 46.3% YoY to ₹33.11 crore. Consolidated Profit After Tax (PAT) grew 22.6% YoY and a substantial 150.8% QoQ to ₹1.42 crore, driven by scale and operating efficiencies. Consolidated EPS for the quarter ended 30 Jun'26 stood at ₹0.29, up from ₹0.24 YoY and ₹0.12 QoQ. Management attributed growth to product portfolio expansion, digital channel scale-up, and improved distribution, while focusing on cost discipline and deeper market penetration.
Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026.
Financial Result · 13 Aug 2026, 11:22 pm
Aayush Wellness Q1 FY27: Strong Revenue Growth and Profit Jump Aayush Wellness reported robust Q1 FY27 results, with consolidated revenue rising 46.3% YoY to ₹33.11 crore. Profit After Tax (PAT) grew 22.6% YoY to ₹1.42 crore and surged 150.8% QoQ, driven by scale and operating leverage. Consolidated EPS stood at ₹0.29, up from ₹0.24 in Q1 FY26. Management attributed growth to product portfolio expansion, digital commerce scale-up, and improved distribution. The company is focusing on deeper penetration in Tier 2/3 markets and exploring export opportunities in the Middle East and South Asia.
Aayush Wellness Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated ....
Intimation · 13 Aug 2026, 5:30 am
Aayush Wellness Board Meeting Scheduled for Aug 13, '26 to Approve Q1 Results Aayush Wellness has scheduled a Board of Directors meeting on Aug 13, '26 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended Jun 30, '26. The company also noted its trading window for designated persons has been closed since Jul 01, '26, and will reopen 48 hours after the financial results are declared.
Declaration of Postal Ballot.
Others (Uncategorized) · 14 Jul 2026, 10:55 pm
Aayush Wellness Board Approves Auditor Appointment and Director Regularisations Aayush Wellness Limited's board, in its meeting on 14 Jul'26, approved key corporate actions. The board appointed A. Raghavendra Rao & Associates as Statutory Auditors to fill a casual vacancy and regularised Mr. Dinesh Dhangare and Mr. Kashiram Jadhav as Non-Executive Non-Independent Directors. These resolutions will be put to shareholder vote via a postal ballot. The e-voting period is scheduled from 19 Jul'26 to 17 Aug'26, with a cut-off date of 10 Jul'26 for determining shareholder eligibility.
Maharashtra''s MCOCA Crackdown on illegal Gutkha Trade Creates Significant Growth Opportunity for Aayush Wellness''s Herbal Masala Business
Press Release · 17 Jun 2026, 3:56 pm
Aayush Wellness Sees Growth Opportunity From Maharashtra's Gutkha Crackdown Aayush Wellness Limited expects a significant growth opportunity for its Herbal Masala business following Maharashtra's crackdown on the illegal gutkha trade using the MCOCA act. This regulatory action on 17 Jun'26 targets the multi-billion rupee illicit market, disrupting supply chains. The company anticipates a consumer shift from banned tobacco products to legal, tobacco-free alternatives. This structural industry change is expected to strengthen the competitive position of compliant players, allowing established brands like Aayush Wellness to gain substantial market share and unlock long-term growth.
Press release on Audited Financial Statements of the Company.
Press Release · 30 May 2026, 12:54 am
Aayush Wellness Reports Strong FY26 Revenue Growth of 112% YoY Aayush Wellness reported strong FY26 results for the year ended 31 Mar'26, with consolidated revenue from operations rising 112% YoY to ₹15,548.20 Lakhs. Total income grew 115% YoY to ₹15,809.20 Lakhs. Net profit increased 18.26% YoY to ₹398.04 Lakhs, with EPS at ₹0.82. For Q4 FY26, revenue was ₹4,840.70 Lakhs, up 117% YoY and 9% QoQ. However, Q4 FY26 net profit declined to ₹56.46 Lakhs from ₹109.31 Lakhs in Q4 FY25, indicating margin pressure.
Audited Standalone & Consolidated Financial Results of the Company for the Quarter and Financial Year ended on March 31, 2026
Outcome · 30 May 2026, 12:41 am
Aayush Wellness Reports Strong FY26 Results with 112% Revenue Growth Aayush Wellness reported strong consolidated results for FY26 ending 31 Mar'26. Revenue from operations grew 112% YoY to ₹15,548.15 lakhs, while total income rose 115% YoY to ₹15,809.17 lakhs. Net profit increased by 18.26% YoY to ₹398.04 lakhs. For Q4 FY26, revenue stood at ₹4,840.70 lakhs, up 117% YoY. However, Q4 net profit declined to ₹56.46 lakhs from ₹109.31 lakhs YoY. Full-year EPS for FY26 was ₹0.82, up from ₹0.69 in FY25. The board approved the results on 29 May'26.
Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026
Financial Result · 30 May 2026, 12:30 am
Aayush Wellness Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakhs) ■ Revenue: 4,841 (+116.6% YoY | +8.7% QoQ) ■ EBITDA: 34.4 (-71.1% YoY | -15.9% QoQ) ■ EBITDA Margin (%): 0.7 (-461 bps YoY | -21 bps QoQ) ■ PAT: 56.5 (-48.3% YoY | -46.4% QoQ) ■ EPS (INR): 0.12 (-45.5% YoY | -45.5% QoQ)
Aayush Wellness Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Audited Standalone & Consolidated ....
Intimation · 29 May 2026, 5:30 am
Aayush Wellness Board Meeting Scheduled for Q4 & FY26 Results Aayush Wellness Limited's Board of Directors will meet on 29 May'26 to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended 31 Mar'26. The agenda also includes reviewing the Auditors' Report. The trading window for designated persons has been closed since 01 Apr'26 and will reopen 48 hours after the results are declared.